Literature DB >> 20303711

The likelihood of participation in clinical trials can be measured: the Clinical Research Involvement Scales.

Paula M Frew1, Su-I Hou, Marsha Davis, Kayshin Chan, Takeia Horton, Justin Shuster, Brooke Hixson, Carlos del Rio.   

Abstract

OBJECTIVE: We developed the Clinical Research Involvement Scales (CRIS) to assess the willingness to participate in a clinical trial. STUDY DESIGN AND
SETTING: Diverse populations (N=919) aged 18 years or older from Atlanta, Georgia, were included in comprehensive testing of the 41-item CRIS instrument. The formative phase focused on item content for the new measures (n=54). Questionnaires from potential vaccine trial participants (n=865), collected at multiple time points, resulted in the evaluation of scale reliability and validity (i.e., attitudes, behavioral and normative beliefs, perceived social support for clinical research participation, social norm compliance, perceptions of the clinical research organization, and perceived relevance of the research endeavor).
RESULTS: Qualitative testing revealed adequate comprehension and content validity of the initial item set. The subjective norms domain (n=3) initially exhibited poor internal consistency in pilot testing (Cronbach's alpha=0.525); yet, rewording of the items resulted in consistently stable measurement improvement (Cronbach's alpha=0.850). Each of the CRIS subscales demonstrated extremely high reliability, ranging from 0.734 to 0.918. Confirmatory factor analysis verified item-factor relationships and determined construct and convergent validity (root mean square error of approximation=0.068; comparative fit index=0.835).
CONCLUSIONS: CRIS is a reliable instrument for measuring community attitudes toward participation in biomedical research studies. Results of this study support the use of these scales to recruit diverse populations to clinical trials. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303711      PMCID: PMC2892193          DOI: 10.1016/j.jclinepi.2009.12.002

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  42 in total

1.  A venue-based method for sampling hard-to-reach populations.

Authors:  F B Muhib; L S Lin; A Stueve; R L Miller; W L Ford; W D Johnson; P J Smith
Journal:  Public Health Rep       Date:  2001       Impact factor: 2.792

2.  Wanted: women in clinical trials.

Authors:  Viviana Simon
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

3.  The influence of religion on organ donation and transplantation among the Black Caribbean and Black African population--a pilot study in the United Kingdom.

Authors:  Cynthia Davis; Gurch Randhawa
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

4.  The Tuskegee Legacy Project: willingness of minorities to participate in biomedical research.

Authors:  Ralph V Katz; S Steven Kegeles; Nancy R Kressin; B Lee Green; Min Qi Wang; Sherman A James; Stefanie Luise Russell; Cristina Claudio
Journal:  J Health Care Poor Underserved       Date:  2006-11

Review 5.  Barriers to participation in HIV drug trials: a systematic review.

Authors:  Edward Mills; Kumanan Wilson; Beth Rachlis; Lauren Griffith; Ping Wu; Gordon Guyatt; Curtis Cooper
Journal:  Lancet Infect Dis       Date:  2006-01       Impact factor: 25.071

6.  New schemes aim to boost minority participation in research.

Authors:  Alisa Opar
Journal:  Nat Med       Date:  2007-06-29       Impact factor: 53.440

7.  Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team.

Authors:  B A Koblin; S Holte; B Lenderking; P Heagerty
Journal:  J Acquir Immune Defic Syndr       Date:  2000-08-15       Impact factor: 3.731

Review 8.  Recruiting minorities into clinical trials: toward a participant-friendly system.

Authors:  G M Swanson; A J Ward
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

9.  Current issues surrounding women and minorities in drug trials.

Authors:  D P Wermeling; A S Selwitz
Journal:  Ann Pharmacother       Date:  1993 Jul-Aug       Impact factor: 3.154

10.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

View more
  17 in total

1.  Development and Psychometric Evaluation of the HPV Clinical Trial Survey for Parents (CTSP-HPV) Using Traditional Survey Development Methods and Community Engagement Principles.

Authors:  Jennifer Cunningham; Kenneth A Wallston; Consuelo H Wilkins; Pamela C Hull; Stephania T Miller
Journal:  Clin Transl Sci       Date:  2015-11-04       Impact factor: 4.689

2.  Socioecological influences on community involvement in HIV vaccine research.

Authors:  Paula M Frew; Matthew Archibald; Brooke Hixson; Carlos del Rio
Journal:  Vaccine       Date:  2011-06-29       Impact factor: 3.641

3.  Sources of racial/ethnic differences in awareness of HIV vaccine trials.

Authors:  Michael P Arnold; Michele Andrasik; Stewart Landers; Shelly Karuna; Matthew J Mimiaga; Steven Wakefield; Kenneth Mayer; Susan Buchbinder; Beryl A Koblin
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

4.  Exception from informed consent for emergency research: consulting the trauma community.

Authors:  Carrie A Sims; Joshua A Isserman; Daniel Holena; Latha Mary Sundaram; Nikolai Tolstoy; Sarah Greer; Seema Sonnad; Jose Pascual; Patrick Reilly
Journal:  J Trauma Acute Care Surg       Date:  2013-01       Impact factor: 3.313

5.  Time will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuation.

Authors:  Paula M Frew; Mark J Mulligan; Su-I Hou; Kayshin Chan; Carlos del Rio
Journal:  Open Access J Clin Trials       Date:  2010-09-01

6.  The Community Liaison Program: a health education pilot program to increase minority awareness of HIV and acceptance of HIV vaccine trials.

Authors:  R T Kelley; A Hannans; G L Kreps; K Johnson
Journal:  Health Educ Res       Date:  2012-02-10

7.  Venue-based recruitment of women at elevated risk for HIV: an HIV Prevention Trials Network study.

Authors:  Danielle F Haley; Carol Golin; Wafaa El-Sadr; James P Hughes; Jing Wang; Malika Roman Isler; Sharon Mannheimer; Irene Kuo; Jonathan Lucas; Elizabeth DiNenno; Jessica Justman; Paula M Frew; Lynda Emel; Anne Rompalo; Sarah Polk; Adaora A Adimora; Lorenna Rodriquez; Lydia Soto-Torres; Sally Hodder
Journal:  J Womens Health (Larchmt)       Date:  2014-04-17       Impact factor: 2.681

8.  Retention strategies and factors associated with missed visits among low income women at increased risk of HIV acquisition in the US (HPTN 064).

Authors:  Danielle F Haley; Jonathan Lucas; Carol E Golin; Jing Wang; James P Hughes; Lynda Emel; Wafaa El-Sadr; Paula M Frew; Jessica Justman; Adaora A Adimora; Christopher Chauncey Watson; Sharon Mannheimer; Anne Rompalo; Lydia Soto-Torres; Zandraetta Tims-Cook; Yvonne Carter; Sally L Hodder
Journal:  AIDS Patient Care STDS       Date:  2014-04       Impact factor: 5.078

9.  Delivering a "dose of hope": a faith-based program to increase older african americans' participation in clinical trials.

Authors:  Paula M Frew; Saad B Omer; Kimberly Parker; Marcus Bolton; Jay Schamel; Eve Shapiro; Lauren Owens; Diane Saint-Victor; Sahithi Boggavarapu; Nikia Braxton; Matthew Archibald; Ameeta S Kalokhe; Takeia Horton; Christin M Root; Vincent L Fenimore; Aaron M Anderson
Journal:  JMIR Res Protoc       Date:  2015-06-02

10.  Associations Among HIV Risk Perception, Sexual Health Efficacy, and Intent to Use PrEP Among Women: An Application of the Risk Perception Attitude Framework.

Authors:  Whitney C Sewell; Rupa R Patel; Stephanie Blankenship; Julia L Marcus; Douglas S Krakower; Phillip A Chan; Kimberly Parker
Journal:  AIDS Educ Prev       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.